{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T17:01:50Z","timestamp":1788454910380,"version":"build-2803163510"},"reference-count":42,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Merck & Co"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.jaci.2016.06.044","type":"journal-article","created":{"date-parts":[[2016,8,11]],"date-time":"2016-08-11T14:38:28Z","timestamp":1470926308000},"page":"1631-1638","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":135,"title":["Efficacy of house dust mite sublingual immunotherapy tablet in North American adolescents and adults in a randomized, placebo-controlled trial"],"prefix":"10.1016","volume":"138","author":[{"given":"Hendrik","family":"Nolte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David I.","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harold S.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Kleine-Tebbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon L.","family":"Sussman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorthe","family":"Seitzberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorte","family":"Rehm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amarjot","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziliang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2016.06.044_bib1","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2332\/allergolint.13-RAI-0650","article-title":"Allergen immunotherapy and tolerance","volume":"62","author":"Matsuoka","year":"2013","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaci.2016.06.044_bib2","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.jaci.2011.12.973","article-title":"SQ-standardized sublingual grass immunotherapy: confirmation of disease modification 2 years after 3 years of treatment in a randomized trial","volume":"129","author":"Durham","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2016.06.044_bib3","first-page":"154","article-title":"Tolerability during double-blind randomized phase I trials with the house dust mite allergy immunotherapy tablet in adults and children","volume":"24","author":"Corzo","year":"2014","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaci.2016.06.044_bib4","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.anai.2015.10.024","article-title":"Safety of house dust mite sublingual immunotherapy standardized quality tablet in children allergic to house dust mites","volume":"116","author":"Maloney","year":"2016","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2016.06.044_bib5","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/j.jaci.2014.12.1911","article-title":"Onset and dose-related efficacy of house dust mite sublingual immunotherapy tablets in an environmental exposure chamber","volume":"135","author":"Nolte","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2016.06.044_bib6","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.jaci.2015.06.036","article-title":"Effective treatment of house dust mite-induced allergic rhinitis with 2 doses of the SQ-HDM SLIT-tablet: results from a randomized double-blind, placebo-controlled phase III trial","volume":"137","author":"Demoly","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2016.06.044_bib7","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.jaci.2014.03.019","article-title":"Standardized quality (SQ) house dust mite sublingual immunotherapy tablet (ALK) reduces inhaled corticosteroid use while maintaining asthma control: a randomized, double-blind, placebo-controlled trial","volume":"134","author":"Mosbech","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2016.06.044_bib8","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1001\/jama.2016.3964","article-title":"Efficacy of a house dust mite sublingual allergen immunotherapy tablet in adults with allergic asthma: A randomized clinical trial","volume":"315","author":"Virchow","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jaci.2016.06.044_bib9","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jaci.2005.05.017","article-title":"Prevalences of positive skin test responses to 10 common allergens in the US population: results from the third National Health and Nutrition Examination Survey","volume":"116","author":"Arbes","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2016.06.044_bib10","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.jaci.2010.11.045","article-title":"House dust mite sublingual immunotherapy: results of a US trial","volume":"127","author":"Bush","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2016.06.044_bib11","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000444016","article-title":"Fractionation of source materials leads to high reproducibility of SQ-HDM SLIT-tablets","volume":"169","author":"Henmar","year":"2016","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2016.06.044_bib12","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jaci.2013.03.039","article-title":"Grading local side effects of sublingual immunotherapy for respiratory allergy: speaking the same language","volume":"132","author":"Passalacqua","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2016.06.044_bib13","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1398-9995.2006.01312.x","article-title":"Recommendations for standardization of clinical trials with allergen specific immunotherapy for respiratory allergy. A\u00a0statement of a World Allergy Organization (WAO) taskforce","volume":"62","author":"Canonica","year":"2007","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2016.06.044_bib14","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.jaci.2013.03.019","article-title":"Randomized controlled trial of a ragweed allergy immunotherapy tablet in North American and European adults","volume":"131","author":"Creticos","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2016.06.044_bib15","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jaci.2010.11.035","article-title":"Efficacy and safety of timothy grass allergy immunotherapy tablet treatment in North American adults","volume":"127","author":"Nelson","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2016.06.044_bib16","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.anai.2014.04.018","article-title":"Safety and tolerability of a short ragweed sublingual immunotherapy tablet","volume":"113","author":"Nolte","year":"2014","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2016.06.044_bib17","unstructured":"Allergenic Products Advisory Committee (APAC) meeting, December 12, 2013. US Food and Drug Administration: 2013."},{"key":"10.1016\/j.jaci.2016.06.044_bib18","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.amjmed.2003.10.030","article-title":"Leukotriene receptor antagonists for allergic rhinitis: a systematic review and meta-analysis","volume":"116","author":"Wilson","year":"2004","journal-title":"Am J Med"},{"key":"10.1016\/j.jaci.2016.06.044_bib19","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.jaci.2011.03.049","article-title":"Subcutaneous immunotherapy and pharmacotherapy in seasonal allergic rhinitis: a comparison based on meta-analyses","volume":"128","author":"Matricardi","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2016.06.044_bib20","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1741-7015-12-71","article-title":"A meta-analysis of sublingual allergen immunotherapy and pharmacotherapy in pollen-induced seasonal allergic rhinoconjunctivitis","volume":"12","author":"Devillier","year":"2014","journal-title":"BMC Med"},{"key":"10.1016\/j.jaci.2016.06.044_bib21","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.jaci.2016.04.061","article-title":"Treatment effect of sublingual immunotherapy tablets and pharmacotherapies for seasonal and perennial allergic rhinitis: pooled analyses","volume":"138","author":"Durham","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2016.06.044_bib22","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1046\/j.1365-2273.2000.00417.x","article-title":"Patient and physician perspectives on the impact and management of perennial and seasonal allergic rhinitis","volume":"25","author":"Scadding","year":"2000","journal-title":"Clin Otolaryngol Allied Sci"},{"key":"10.1016\/j.jaci.2016.06.044_bib23","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1365-2222.2010.03654.x","article-title":"Efficacy of fluticasone furoate nasal spray vs. placebo for the treatment of ocular and nasal symptoms of allergic rhinitis: a systematic review","volume":"41","author":"Rodrigo","year":"2011","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2016.06.044_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40521-014-0040-y","article-title":"Mite-allergic rhinitis: how to evaluate clinical efficacy in allergen-specific immunotherapy trials?","volume":"2","author":"Pfaar","year":"2015","journal-title":"Curr Treat Options Allergy"},{"key":"10.1016\/j.jaci.2016.06.044_bib25","first-page":"116","article-title":"The Hawthorne effect in educational research","volume":"44","author":"Cook","year":"1962","journal-title":"Phi Delta Kappan"},{"key":"10.1016\/j.jaci.2016.06.044_bib26","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1586\/1744666X.2014.963556","article-title":"Oral\/sublingual Phleum pretense grass tablet (Grazax\/Grastek) to treat allergic rhinitis in the USA","volume":"10","author":"Nelson","year":"2014","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.jaci.2016.06.044_bib27","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.anai.2013.11.018","article-title":"Efficacy and safety of grass sublingual immunotherapy tablet, MK-7243: a large randomized controlled trial","volume":"112","author":"Maloney","year":"2014","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2016.06.044_bib28","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jaci.2010.11.034","article-title":"Efficacy and safety of timothy grass allergy immunotherapy tablets in North American children and adolescents","volume":"127","author":"Blaiss","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2016.06.044_bib29","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.anai.2013.03.013","article-title":"Randomized controlled trial of ragweed allergy immunotherapy tablet efficacy and safety in North American adults","volume":"110","author":"Nolte","year":"2013","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2016.06.044_bib30","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/j.jaci.2013.09.004","article-title":"An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies","volume":"132","author":"Calderon","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2016.06.044_bib31","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/ACI.0000000000000104","article-title":"Update on house dust mite immunotherapy: are more studies needed?","volume":"14","author":"Nelson","year":"2014","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2016.06.044_bib32","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/j.1398-9995.2006.01095.x","article-title":"Randomized double-blind controlled study with sublingual carbamylated allergoid immunotherapy in mild rhinitis due to mites","volume":"61","author":"Passalacqua","year":"2006","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2016.06.044_bib33","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1398-9995.2004.00456.x","article-title":"Allergic rhinitis due to house dust mites: evaluation of the efficacy of specific sublingual immunotherapy","volume":"59","author":"Tonnel","year":"2004","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2016.06.044_bib34","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/cea.12039","article-title":"House dust mite sublingual immunotherapy: a double-blind, placebo-controlled study in elderly patients with allergic rhinitis","volume":"43","author":"Bozek","year":"2013","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2016.06.044_bib35","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.jaci.2013.11.012","article-title":"Efficacy and safety of sublingual tablets of house dust mite allergen extracts in adults with allergic rhinitis","volume":"133","author":"Bergmann","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2016.06.044_bib36","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1002\/lary.23935","article-title":"Fast onset of action of sublingual immunotherapy in house dust mite-induced allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial","volume":"123","author":"Wang","year":"2013","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jaci.2016.06.044_bib37","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1398-9995.1997.tb00991.x","article-title":"Specific immunotherapy with Dermatophagoides pteronyssinus and D. farinae results in decreased bronchial hyperreactivity","volume":"52","author":"Pichler","year":"1997","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2016.06.044_bib38","doi-asserted-by":"crossref","first-page":"e104","DOI":"10.2500\/ajra.2010.24.3508","article-title":"Efficacy and safety of a glutaraldehyde-modified house dust mite extract in allergic rhinitis","volume":"24","author":"Riechelmann","year":"2010","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.jaci.2016.06.044_bib39","doi-asserted-by":"crossref","first-page":"233","DOI":"10.12932\/AP0276.31.3.2013","article-title":"Two year follow-up of clinical and inflammation parameters in children monosensitized to mites undergoing subcutaneous and sublingual immunotherapy","volume":"31","author":"Yukselen","year":"2013","journal-title":"Asian Pac J Allergy Immunol"},{"key":"10.1016\/j.jaci.2016.06.044_bib40","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(97)07055-4","article-title":"Randomised controlled trial of local allergoid immunotherapy on allergic inflammation in mite-induced rhinoconjunctivitis","volume":"351","author":"Passalacqua","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2016.06.044_bib41","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jaci.2008.10.044","article-title":"Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy","volume":"123","author":"Bufe","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2016.06.044_bib42","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jaci.2006.05.003","article-title":"Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis","volume":"118","author":"Dahl","year":"2006","journal-title":"J Allergy Clin Immunol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674916307837?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674916307837?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:01:43Z","timestamp":1758790903000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674916307837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S0091674916307837"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2016.06.044","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of house dust mite sublingual immunotherapy tablet in North American adolescents and adults in a randomized, placebo-controlled trial","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2016.06.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}